Skip to main content
OpenTrials

Clinical trial condition

Interstitial Lung Diseases

Explore clinical trials studying Interstitial Lung Diseases. Study availability and eligibility vary by location and protocol.

28 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Interstitial Lung Diseases trial results

Recruiting

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

NCT07201922

Conditions
Familial Pulmonary Fibrosis, Interstitial Lung Abnormalities, Interstitial Lung Diseases, +3 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Clinical Research Specialists LLC - Kissimmee Kissimmee, Florida, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
View all 55 locations
View Trial Details
Recruiting

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

NCT06328777

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +10 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
View Trial Details
Recruiting

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

NCT06806592

Conditions
Interstitial Lung Diseases, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic-Arizona Scottsdale, Arizona, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Paradigm Clinical Research - San Diego San Diego, California, United States
View all 156 locations
View Trial Details
Not yet recruiting

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

NCT07540988

Conditions
Interstitial Lung Diseases, Lung Diseases, Lung Diseases, Interstitial, +1 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • Newport Native MD, Inc Newport Beach, California, United States
  • Clinical Research Specialists LLC - Kissimmee Kissimmee, Florida, United States
View all 151 locations
View Trial Details

Related conditions